TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15049 · Aug 12

#java#distributed_systems#durable_execution#grpc#java#javascript#microservice_orchestration#orchestration_engine#orchestrator#reactjs#spring_boot#workflow_automation#workflow_engine#workflow_management#workflows Conductor is an open-source tool that helps you manage and automate complex workflows involving many microservices and systems. It makes your workflows flexible, reliable, and scalable by handling retries, errors, and monitoring automatically. You can define workflows as code in JSON, use various task types, and manage workflows dynamically without tightly coupling services. It offers an easy-to-use web interface and supports multiple databases like Redis and MySQL. This helps you build, run, and monitor workflows efficiently, saving time and reducing errors in managing distributed applications. It also has SDKs for Java, Python, JavaScript, Go, and C# to integrate easily with your projects. https://github.com/conductor-oss/conductor

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment